7MM COVID-19 Vaccines Industry Forecast Report, 2021-2026 - Etiology, Pathophysiology, Epidemiology, Current Vaccination Options, Unmet Need & Opportunities, Pipeline Assessment, R&D Strategies

Dublin, Jan. 17, 2022 (GLOBE NEWSWIRE) -- The "Coronavirus Disease 2019 (COVID-19) Vaccines Market Forecast to 2026" report has been added to *ResearchAndMarkets.com's* offering.

*This publication is an update and extension to the Excel model containing the patient-based sales forecast for COVID-19 vaccines.*

· Report deliverables include a PowerPoint report and an interactive Excel-based forecast model
· Forecasts includes 7MM (US, France, Germany, Italy, Spain, UK, and Japan)
· Forecasts cover 5 years from 2021 to 2026

*The report forecasts three different potential scenarios for the future use of COVID-19 vaccines:*

· The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
· The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
· In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.

*Scope of the Report*

· Executive Summary
· Disease Overview: History of the outbreak, Etiology and Pathophysiology
· Epidemiology
· Current Vaccination Options: Includes detailed product profiles with SWOT analysis
· Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
· Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
· R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
· Market Outlook

*Reasons to Buy*

· To understand the current COVID-19 vaccine situation in multiple regions.
· Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
· Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
· Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
· Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
· Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

* Companies Mentioned*

· Pfizer
· BioNTech
· Moderna
· AstraZeneca
· Johnson & Johnson
· Novavax
· Sanofi
· GlaxoSmithKline

For more information about this report visit https://www.researchandmarkets.com/r/aendpq

CONTACT: CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900